Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-010605
Filing Date
2026-02-23
Accepted
2026-02-23 16:08:23
Documents
1
Period of Report
2026-02-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1771880900.html 4  
1 FORM 4 wk-form4_1771880900.xml 4 2978
  Complete submission text file 0001628280-26-010605.txt   4550
Mailing Address C/O AYALA PHARMACEUTICALS, INC. OPPENHEIMER 4 REHOVOT L3 7670104
Business Address
Gordon Gary B. (Reporting) CIK: 0001811354 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39813 | Film No.: 26665188

Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Issuer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)